300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ireland
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Lanting Capital, VC Fund

Lanting Capital

VC Fund

Hangzhou, China

Lanting Capital is a venture capital firm that focuses on healthcare industry and especially pharmaceuticals.LTC is founded by pharmaceutical veterans and asset management experts. Lan Ting Capital is a cross-border, pharmaceutical focused strategic consulting and investment firm.LTC leverages their unparalleled industry knowledge and networkplus deep financial market know-how across the US, China and Europe to unlock unique cross-border growth opportunities for our portfolio companies and investors.

Total investments:
12
Last investment:
Lead investor:
0%

Last updated:

Industries Lanting Capital invests in

MedicalBiotechnologyPharmaceuticalRoboticsInternet of Things

Stages Lanting Capital invests in

Series ASeries BSeries CVenture - Series Unknown

Countries Lanting Capital invests in

ChinaUnited States

Contacts

NameEmailPhoneSocials
Amy Xu
Ethan Wu
Marc Roualet
Robert Bloder Robert Bloder

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 3 (25%)
  • Biotechnology 3 (25%)
  • Pharmaceutical 3 (25%)
  • Robotics 2 (17%)
  • Internet of Things 2 (17%)
See all 17 industries →

Stage

  • Series A 6 (50%)
  • Series B 3 (25%)
  • Series C 2 (17%)
  • Venture - Series Unknown 1 (8%)

Country

  • China 9 (75%)
  • United States 1 (8%)

Team

NameTitleInvestmentsLinksEmail
Amy Xu Investment Director
Investment Director Total investments: 0 Find email
Ethan Wu Chief Executive Officer
Chief Executive Officer Total investments: 0 Find email
Marc Roualet Chief Legal Director
Chief Legal Director Total investments: 0 Find email
Robert Bloder
Robert Bloder Partner
Partner Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Innogen Pharmaceutical Innogen Pharmaceutical
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. Venture - Series Unknown / Jul 19, 2022
Rona Therapeutics Rona Therapeutics
Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines. $33M / Series A / Apr 07, 2022
Innogen Pharmaceutical Innogen Pharmaceutical
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. $120M / Series A / Dec 23, 2021
Yinuo Pharmaceutical Yinuo Pharmaceutical
Yinuo Pharmaceuticals is a small molecule inhibitor drug developer. $120M / Series A / Dec 23, 2021
Regor Therapeutics Regor Therapeutics
Regor Therapeutics is a clinical-stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, andclinical development. Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules. $90M / Series B / Feb 18, 2021
Yunji Technology Yunji Technology
Yunji Technology is a Chinese robot company that builds a commercial service robot capable of delivering goods. $27.8M / Series C / Jan 19, 2021
Immvira Immvira
Immvira was founded in Shenzhen China in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. Series C / Dec 31, 2020
Green Rice Technology
Green Rice Technology is Smart Home Devices Provider Company. $20M / Series B / Dec 06, 2018
DeepTech DeepTech
DeepTech is a resource empowerment and service organization focusing on emerging technologies. It focuses on the free links of emerging technology elements around the world, serving industries, governments, universities, research institutes, capital, and more. Series A / Nov 12, 2018
Kuandeng Kuandeng
Kuandeng specializes in developing a variety of applications for autonomous driving through the intelligent crowdsourcing of a map. Its core technologies include deep learning, image recognition, 3D vision, robotics, map construction, and big data cloud services based on it. The company has been corporating with a number of car manufacturers withits commitment to productize autonomous driving technology. It has completed several hundred million financings led by IDG Capital. Kuandeng was founded by Liu Jun, former vice president of Baidu and head of the LBS business unit. $14.2M / Series A / Feb 28, 2018
See all 12 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ireland
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Lanting Capital invest in?

Lanting Capital invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 12 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Lanting Capital?

Public channels for Lanting Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Lanting Capital?

The team at Lanting Capital includes Amy Xu (Investment Director), Ethan Wu (Chief Executive Officer) and Marc Roualet (Chief Legal Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Lanting Capital Lanting Capital Find emails